Numab Therapeutics is an oncology-focused biopharmaceutical company based in Zurich-area,
Switzerland. At Numab, we are writing the next chapter in cancer immunotherapy by creating multispecific antibodies that enable the pursuit of novel therapeutic strategies. With our proprietary MATCH™
technology platform we are fueling a new wave of multi-specific drug candidates engineered with
versatility and developability in mind...
Numab Therapeutics is an oncology-focused biopharmaceutical company based in Zurich-area,
Switzerland. At Numab, we are writing the next chapter in cancer immunotherapy by creating multispecific antibodies that enable the pursuit of novel therapeutic strategies. With our proprietary MATCH™
technology platform we are fueling a new wave of multi-specific drug candidates engineered with
versatility and developability in mind. Our lead product was designed to balance potent anti-tumor
immunity with a desirable safety profile by targeting 4-1BB, PD-L1 and Human Serum Albumin
simultaneously.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.